A retrospective study of the efficacy and safety of Almonertinib in the treatment of locally advanced or brain metastatic non-small cell lung cancer with EGFR-positive …
M Gao, K Li, G Chen, Z Yang, B Xu, Y Cai, M Liu… - 2024 - researchsquare.com
Objective: To retrospectively analyze the efficacy and safety of Almonertinib in locally
advanced or brain metastatic non-small cell lung cancer (NSCLC) with EGFR-positive …
advanced or brain metastatic non-small cell lung cancer (NSCLC) with EGFR-positive …